91桃色APP

This cooperation is aimed at forming research, educational and informational ties between the RUDN and Evalar.

“The RUDN is one of the leading federal universities in Russia, — commented Andrei Alexandrovich Kostin. — The ‘Evalar’ company is one of the top Russian pharmaceutical companies and for many years has been the leader in the Russian segment of dietary supplements. We are also united by our international status. RUDN is the most international university in Russia, the center of network interaction of universities of BRICS, SCO and CIS countries. Representatives of 160 countries study here. The company ‘Evalar’ actively expands into the world pharmaceutical market. The company’s products are registered and supplied to more than 20 countries, including countries of Western and Eastern Europe, the Middle East and the Mediterranean. Collaboration agreement will allow to use intellectual and material-technical potential of RUDN and ‘Evalar’ company in the most full and effective way to achieve the set goals. The joint projects we have planned will contribute to the further development of practical healthcare through the buildup of scientific, intellectual and professional resources”.

Priority areas of cooperation within the framework of the agreement, in particular, include:

• Joint development of modern biologically active food supplements and medicinal preparations of plant origin corresponding to modern trends of nutritiology and dietetics in Russian and international practice;
• Using RUDN scientific-research base, experience and elaborations on collaboration directions in practical activity of “Evalar” JSC;
• Carrying out joint scientific and scientific-applied research;
• Provision of high quality training, retraining and advanced training of specialists, including involvement of experts — representatives of “Evalar” JSC — to participate in elaboration of University educational programs;
• Preparation and conduct of scientific and educational activities and conferences on topics related to areas of cooperation;
• Organization of traineeships and internships for PFUR students in “Evalar” JSC;
• Organization of partner scientific and educational projects, courses and mini-courses of lectures and seminars, individual educational lectures for “Evalar” JSC, the University and for an unlimited number of people;
• Establishment of joint grants and scholarships for carrying out research in topical spheres of cooperation of mutual interest.

For reference

JSC “Evalar” is one of the largest pharmaceutical companies in Russia, occupying the second place among the domestic pharmaceutical manufacturers according to DSM-Group for January 2021. Absolute national leader in the volume of natural drugs for health preservation and promotion. The first company in Russia, which implemented the principle of a full production cycle — from cultivation of herbal raw materials, to packaging of finished products.

In 2019, “Evalar” launched the second production complex for the production of medicines, which allowed to increase the company’s production capacity by one and a half times. The assortment portfolio of “Evalar” includes more than 300 items of dietary supplements and medicines in various forms of production.

In 2016, Evalar passed the national audit of the Ministry of Industry and Trade of the Russian Federation for compliance with GMP rules; since 2014, the company annually confirms compliance of its production complex and manufacturing processes with the rules of good manufacturing practices of the National Sanitary Protection Fund of the Food and Drug Administration of the US Department of Health and Human Services, which is confirmed by the relevant GMP certificate.

The company exports its products to more than 20 countries. The Evalar brand is represented on the world’s largest online marketplaces: Alibaba.com and Amazon.com.